openPR Logo
Press release

Pulmonary Edema Market Approx CAGR of 7.2% with Topmost Players Pfizer Inc., ARGON MEDICAL, Edwards Lifesciences Corporation, Alcaliber S.A., Lupin Pharmaceuticals, Inc. and More

01-29-2019 10:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Pulmonary Edema Market

Pulmonary Edema Market

MarketResearchFuture.com Added a Most Valuable Research Report Global “Pulmonary Edema Market” Pulmonary Edema Market Ready to Register a Double Digit CAGR During 2018 to 2023.

Key Players for Global Pulmonary Edema Market

Pfizer Inc. (U.S.), ARGON MEDICAL (U.S.), Edwards Lifesciences Corporation (U.S.), BD (U.S.), Alcaliber S.A. (Spain), Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), and Canon Medical Systems Corporation (Japan).

Get Prime Sample Copy at https://www.marketresearchfuture.com/sample_request/5607

Segmentation for Global Pulmonary Edema Market

The global pulmonary edema market is segmented on the basis of type, diagnosis, treatment, and end user.On the basis of the type, the market is segmented into cardiogenic edema, cardiogenic edema, and others.

On the basis of the diagnosis, the market is categorized into blood tests, imaging, and others. The blood tests segment is sub-segmented into b-type natriuretic peptide (BNP), blood count test, kidney function test, and others.

The imaging segment is sub-segmented into chest x-ray, electrocardiogram, echocardiogram, transesophageal echocardiography, pulse oximetry, and others.

On the basis of the treatment, the market is segmented into preload reducers, morphine, suction catheter, and others. The preload reducers segment is sub-segmented into nitroglycerin, diuretics, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Market Highlights for Global Pulmonary Edema Market

Increasing prevalence of pulmonary edema and diseases like kidney failure, heart diseases, and others along with the growing geriatric population boosts the market growth. On the other hand, low per capita healthcare expenditure in the middle and low-income countries, and lack of awareness about the disease are estimated to restrain the market growth.

The global pulmonary edema market is expected to grow at an approximate CAGR of 7.2% during the forecast period.

Regional Analysis for Global Pulmonary Edema Market

America dominates the Global Pulmonary Edema Market owing to a well-developed healthcare sector and high per capita healthcare expenditure. Moreover, the presence of developed economies like U.S. and Canada and Global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the regional boundaries of the Americas fuels the market growth.

Browse Complete 90 Pages Premium Research Report Enabled with 92 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/pulmonary-edema-market-5607

Europe is the second largest Pulmonary Edema Market and is followed by the Asia Pacific due to the availability of funds for research, the presence of developed economies like France, Italy, and Germany within the region.

The Asia Pacific is the fastest growing region in the market due to the presence of developing economies like India and China within the region. Moreover, rising healthcare expenditure and favorable government policies drive the market growth.

The Middle East & Africa holds the least share of the Global Pulmonary Edema Market.  Presence of poor economies, especially within in the African region makes the market to lag. Middle East accounts for the majority of the market share in the Middle East & Africa region due to a huge healthcare expenditure by the presence of the developed economies such as Saudi Arabia, Kuwait, and Qatar within the region.

Some Brief Table of Contents of Report

Chapter 1. Report Prologue  

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study 

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Enquire for Discount at https://www.marketresearchfuture.com/check-discount/5607

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Edema Market Approx CAGR of 7.2% with Topmost Players Pfizer Inc., ARGON MEDICAL, Edwards Lifesciences Corporation, Alcaliber S.A., Lupin Pharmaceuticals, Inc. and More here

News-ID: 1541322 • Views:

More Releases from Market Research Future

CCTV Camera Market Valued at USD 14.8 Billion in 2024, Projected to Reach USD 58.05 Billion by 2035
CCTV Camera Market Valued at USD 14.8 Billion in 2024, Projected to Reach USD 58 …
The CCTV Camera Market is witnessing significant growth driven by rising security concerns, urbanization, and increasing adoption across commercial, residential, and industrial sectors. The market was valued at USD 14.8 Billion in 2024 and is projected to reach USD 58.05 Billion by 2035, growing at a CAGR of 13.23% during the forecast period 2025-2035. Technological advancements such as AI-enabled cameras, high-resolution imaging, and cloud-based surveillance solutions are further propelling market
Ethernet PHY Chip Market Valued at USD 11.25 Billion in 2024, Projected to Reach USD 28.46 Billion by 2035
Ethernet PHY Chip Market Valued at USD 11.25 Billion in 2024, Projected to Reach …
The Ethernet PHY Chip Market is experiencing robust growth, driven by the increasing demand for high-speed networking solutions across data centers, telecommunications, and enterprise networks. The market was valued at USD 11.25 Billion in 2024 and is projected to reach USD 28.46 Billion by 2035, growing at a CAGR of 8.8% during the forecast period 2025-2035. The rising need for faster data transmission, higher bandwidth, and reliable connectivity are key
Semiconductor Production Equipment Industry Expected to Expand from USD 162.57 Million in 2025 to USD 353.98 Million by 2035
Semiconductor Production Equipment Industry Expected to Expand from USD 162.57 M …
The Semiconductor Production Equipment Market is witnessing steady growth driven by rising demand for semiconductors across consumer electronics, automotive, and industrial applications. The market was valued at USD 150.4 Million in 2024 and is projected to reach USD 353.98 Million by 2035, growing at a CAGR of 8.09% during the forecast period 2025-2035. Increasing adoption of advanced semiconductor fabrication technologies and government support for semiconductor manufacturing are key factors fueling
Industrial Lighting Market Size Hits USD 9.7 Billion in 2024, Forecast to Grow at 7.0% CAGR Through 2035
Industrial Lighting Market Size Hits USD 9.7 Billion in 2024, Forecast to Grow a …
The Industrial Lighting Market is witnessing robust growth driven by increasing industrialization, energy efficiency initiatives, and the adoption of smart lighting solutions. The market was valued at USD 9.7 Billion in 2024 and is projected to reach USD 20.42 Billion by 2035, growing at a CAGR of 7.0% during the forecast period 2025-2035. Rising demand for LED-based lighting systems and automation in factories are key factors propelling market expansion globally. Competitive

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments